Akselerasi Proteksi Tenaga Kesehatan Masa Depan: Vaksin HBV sebagai Langkah Preventif Dini Hepatitis B pada Mahasiswa Kesehatan
DOI:
https://doi.org/10.37287/jpm.v8i2.2208Keywords:
hepatitis B, kejadian ikutan pasca imunisasi (KIPI), kesehatan kerja, mahasiswa kesehatan, vaksinAbstract
Mahasiswa kesehatan merupakan kelompok yang berisiko tinggi terpapar virus hepatitis B akibat kontak dengan darah dan cairan tubuh selama praktik klinik. Meskipun efektivitas vaksin rekombinan sangat tinggi, cakupan vaksinasi di kalangan kelompok berisiko ini masih belum optimal. Kegiatan Pengabdian kepada Masyarakat bertujuan meningkatkan proteksi dini mahasiswa kesehatan melalui program vaksinasi hepatitis B. Sasaran adalah mahasiswa tingkat satu dan dua di Fakultas Teknologi Laboratorium Medik Universitas Muhammadiyah Palangkaraya sebanyak 88 peserta. Pelaksanaan kegiatan meliputi edukasi mengenai manfaat vaksinasi, skrining dan pemberian vaksin dan pemantauan KIPI. Evaluasi dilakukan berdasarkan cakupan vaksinasi lengkap dan keamanan pelaksanaan program. Hasil kegiatan menunjukkan bahwa seluruh peserta berhasil menyelesaikan rangkaian vaksinasi hepatitis B (100%). Tidak ditemukan KIPI derajat berat maupun reaksi anafilaksis hanya nyeri pada area penyuktikan (3,41%) dan demam atau subfebris (1,14%) serta tidak ditemukan kemerahan atau pembengkakan pada lokasi penyuntikan, sakit kepala atau pusing, lemas atau kelelahan maupun reaksis sistemik lainnya. Program vaksinasi menunjukkan profil tolerabilitas yang baik selama pemantauan serta mendukung penerapan program vaksinasi sebagai upaya proteksi dini.
References
Ali, A. S., Hussein, N. A., Elmi, E. O. H., Ismail, A. M., & Abdi, M. M. (2023). Hepatitis B vaccination coverage and associated factors among medical students: a cross-sectional study in Bosaso, Somalia, 2021. BMC Public Health, 23(1). https://doi.org/10.1186/s12889-023-15992-2
Chapagain, N., & Chapagain, S. (2023). Need for Hepatitis B Vaccination in Medical Students. Journal of the Nepal Medical Association, 61(262), 569–570. https://doi.org/10.31729/jnma.8189
Fitzgerald, B., Kenzie, W. R. Mac, Rasmussen, S. A., Leahy, M. A., Martinroe, J. C., Spriggs, S. R., Yang, T., Doan, Q. M., King, P. H., Maitland, P. D., Starr, T. M., Yang, M., Jones, T. F., Boulton, M. L., Caine, V. A., Daniel, K. L., Fielding, J. E., Fleming, D. W., Halperin, W. E., … Schaffner, W. (2018). Morbidity and Mortality Weekly Report Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices Recommendations and Reports Centers for Disease Control and Prevention MMWR Editorial and Production Staff (Serials) MMWR Editorial Board. In Recommendations and Reports (Vol. 67, Number 1).
Gong, X., Fang, Q., Zhong, J., Zheng, C., & Yin, Z. (2024). Adverse event reporting following immunization of hepatitis B vaccine: A 13-year review. Taylor & Francis, 20(1), 1–7. https://doi.org/10.1080/21645515.2024.2411824
Hassan, Y. S. A., Hassan, S. A., & Ahmed, N. R. (2023). Uptake of hepatitis B vaccination and associated factors among health sciences students, Mogadishu, Somalia. Frontiers in Public Health, 11. https://doi.org/10.3389/fpubh.2023.1203519
Nguyen, B., Vo, L., Nguyen, T., Vo, M., Pham, T., Nguyen, H., Boyer-Chu, L., & Huynh, G. (2023). Hepatitis B vaccination status and associated factors among health science students. Asian Pacific Journal of Tropical Medicine, 16(5), 213–219. https://doi.org/10.4103/1995-7645.377742
Vesikari, T., Finn, A., van Damme, P., Leroux-Roels, I., Leroux-Roels, G., Segall, N., Toma, A., Vallieres, G., Aronson, R., Reich, D., Arora, S., Ruane, P. J., Cone, C. L., Manns, M., Cosgrove, C., Faust, S. N., Ramasamy, M. N., Machluf, N., Spaans, J. N., … Diaz-Mitoma, F. (2021). Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine A Phase 3 Randomized Clinical Trial. JAMA Network Open, 4(10), 1–13. https://doi.org/10.1001/jamanetworkopen.2021.28652
Walayat, S., Ahmed, Z., Martin, D., Puli, S., Cashman, M., & Dhillon, S. (2015). Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine. World Journal of Hepatology, 7(24), 2503–2509. https://doi.org/10.4254/wjh.v7.i24.2503
World Health Organization. (2024). Global Hepatitis Report 2024 : Action for Access in Low- and Middle-Income Countries. World Health Organization.
Zhou, H., Yang, J., Zhang, J., Liu, P., & Yao, D. (2025). A real-world pharmacovigilance analysis of hepatitis B vaccine using the U.S. Vaccine Adverse Event Reporting System (VAERS) database. Scientific Reports, 15(1), 1–10. https://doi.org/10.1038/s41598-025-90135-8
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Noni Widiawatie, Noor Fadillah, Al Hidayani, Sri Suhartini, Fitria Hariati, Fera Sartika
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
